| 000 | 01070 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516075152.0 | ||
| 264 | 0 | _c20120411 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1442-9071 | ||
| 024 | 7 |
_a10.1111/j.1442-9071.2011.02581.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTroutbeck, Robyn | |
| 245 | 0 | 0 |
_aTherapeutic targeting of the complement system in age-related macular degeneration: a review. _h[electronic resource] |
| 260 |
_bClinical & experimental ophthalmology _c |
||
| 300 |
_a18-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aComplement Inactivating Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aComplement System Proteins _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacular Degeneration _xdrug therapy |
| 700 | 1 | _aAl-Qureshi, Salmaan | |
| 700 | 1 | _aGuymer, Robyn H | |
| 773 | 0 |
_tClinical & experimental ophthalmology _gvol. 40 _gno. 1 _gp. 18-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1442-9071.2011.02581.x _zAvailable from publisher's website |
| 999 |
_c21516642 _d21516642 |
||